Skip to main content

Table 11 Correlation between UGT1A1 genetic polymorphisms and irinotecan dose reduction in patients with CRC

From: Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang

Irinotecan dose reduction

UGT1A1*28

P

UGT1A1*6

P

TA6/6

Number (%)

TA6/7 + TA7/7

Number (%)

G/G

Number (%)

G/A

Number (%)

Yes

6 (10.0)

9 (45.0)

0.014

7 (10.6)

8 (40.0)

0.007

No

54 (90.0)

11 (55.0)

59 (89.4)

12 (60.0)